FDA Enforcement Class II Ongoing

BRAVO PH CAPS DELIVERY DEV5-PK, FGS-0312/FGS-0313 - Product Usage: intended to be used for gastroesophageal pH measurement and monitoring of gastric reflux in adults and children from 4 years of age.

Recall: Z-1335-2021 · Reported April 7, 2021

Enforcement

Recall Number
Z-1335-2021
Event ID
87396
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Covidien Llc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
April 7, 2021
Initiation Date
February 26, 2021
Classification Date
April 1, 2021
Address
15 Hampshire St, Mansfield, MA, 02048-1113, United States

Description

BRAVO PH CAPS DELIVERY DEV5-PK, FGS-0312/FGS-0313 - Product Usage: intended to be used for gastroesophageal pH measurement and monitoring of gastric reflux in adults and children from 4 years of age.

Reason

The capsule may fail to attach to the esophageal mucosa, which in turn may lead to the aspiration of the capsule. In the event of capsule aspiration, immediate intervention to remove the capsule is required. Potential outcomes following capsule aspiration include low oxygen saturation, intervention to retrieve the capsule, potential need to intubate the patient, extended hospital stay and a delay of treatment. Thirteen reports of capsule aspiration have been received the last 2 years.

Code Info

49349Q 49350Q 49351Q 49352Q 49799Q 49800Q 49801Q 49802Q 49809Q 49849Q 49850Q 49851Q 50392Q 50393Q 50492Q 50493Q 50494Q 50495Q 50496Q 50497Q 50615Q 50616Q 50868Q 50869Q 50870Q 50871Q 50872Q 50873Q 50874Q 50875Q 50876Q 50877Q 50878Q 50879Q 50880Q 50881Q

Distribution

Worldwide distribution - US Nationwide distribution.

Quantity

62551